Samples From Leukemia Patients and Their Donors to Identify Specific Antigens

Status unconfirmed

Conditions studied: Acute Myeloid Leukemia

In brief

The purpose of this project is to develop a process to identify highly personalized antigens that are uniquely expressed by the patient's own leukemia cells that can be used for cellular immune therapy.

Key facts

Study ID

NCT02667093

Run by

PersImmune, Inc

People needed

50

Starts

2013-01-01

Expected to finish

2020-12-01

Last updated by the study team

2020-03-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of AML with plan to receive a bone marrow transplant

You may not qualify if…

• NA

Where it is running

• University of California San Diego — La Jolla, California, United States
• Northside Hospital — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.